Senior insider sale
CLO & Secretary at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$4.08M
20K shares
What this filing means
REARDON ANDREW plans to sell 20K shares of LIGAND PHARMACEUTICALS INC valued at approximately $4.08M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001950047-26-002204
Officer· CLO & Secretary
Since Mar 2026
20K
Shares to sell
$4.08M
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
3/4/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | Exercise of Stock Options Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$4.08M
3/4/2026
Total
Units
20K
Value
$4.08M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 20K | $4.08M | NASDAQ | Planned |
| Total | 20K | $4.08M | ||